Author

Rui-Kang Liu

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Natural Products Modulate Plaque Macrophage Functional Programs in Atherosclerosis

Abstract Atherosclerosis is a chronic inflammatory and immunometabolic disease in which plaque macrophages integrate lipid-derived danger signals, metabolic stress and cell-death cues to shape foam-cell formation, necrotic-core expansion, fibrous-cap integrity and plaque vulnerability. Moving beyond the conventional M1...

Kai Yang, Shi-Yi Tao, Rui-Kang Liu et al. · Drug Design, Development and... · 0 citations

Review Open access Aug 2026

Comparative effectiveness of dietary supplements in dilated cardiomyopathy: a systematic review and network meta-analysis

Dilated cardiomyopathy (DCM) is a major cause of heart failure and cardiovascular mortality, partly due to impaired myocardial energy metabolism. Dietary supplements may offer benefits through improved mitochondrial function and antioxidant effects, and randomized controlled trials (RCTs) suggest they can enhance...

Yi-Ying Liu, Rui-Kang Liu, Jun Li et al. · BMC Cardiovascular Disorders · 0 citations

Open access Sep 2026

Long-term efficacy and impact on rehospitalization of Qishen granules in patients with hypertension and heart failure with reduced ejection fraction: a multicenter, randomized, double-blind, placebo-controlled trial protocol

Clinical evidence supporting the therapeutic benefits and safety of QSG in the management of hypertension with HFrEF may establish clinical evidence supporting the therapeutic benefits and safety of QSG in patients with hypertension and HFrEF.

Fu-Yuan Zhang, Zhao-Rui Cui, Zi-Rui Wang et al. · Frontiers in Cardiovascular... · 0 citations